Description
Global leader in development and manufacturing of specialist and complex APIs with 50+ years experience (formerly Johnson Matthey Health, acquired by Altaris Capital in 2022). 900 employees, 5 facilities. Expertise in ADCs, PEGs, lipids, PROTACs and TIDES. 200+ active DMFs.